Works matching IS 03656233 AND DT 2004 AND VI 337 AND IP 6

Results: 7
    1

    [1, 2-Bis(2, 6-difluoro-3-hydroxyphenyl)ethylene-diamine]platinum(II) Complexes, Compounds for the Endocrine Therapy of Breast Cancer - Mode of Action I: Antitumor Activity Due to the Reduction of the Endogenous Estrogen Level.

    Published in:
    Archiv der Pharmazie, 2004, v. 337, n. 6, p. 335, doi. 10.1002/ardp.200300855
    By:
    • Sabine Schertl;
    • Rolf W. Hartmann;
    • Christine Batzl-Hartmann;
    • Günther Bernhardt;
    • Thilo Spruß;
    • Karin Beckenlehner;
    • Marion Koch;
    • Rudolf Krauser;
    • Richard Schlemmer;
    • Helmut Schönenberger
    Publication type:
    Article
    2
    3
    4
    5
    6

    [1, 2-Bis(2, 6-difluoro-3-hydroxyphenyl)ethylene-diamine]platinum(II) Complexes, Compounds for the Endocrine Therapy of Breast Cancer - Mode of Action II: Contribution of Drug Inactivation, Cellular Drug Uptake and Sterical Factors in the Drug-Target Interaction to the Antitumor Activity

    Published in:
    Archiv der Pharmazie, 2004, v. 337, n. 6, p. 349, doi. 10.1002/ardp.200300856
    By:
    • Sabine Schertl;
    • Rolf W. Hartmann;
    • Christine Batzl-Hartmann;
    • Günther Bernhardt;
    • Thilo Spruß;
    • Karin Beckenlehner;
    • Marion Koch;
    • Rudolf Krauser;
    • Richard Schlemmer;
    • Helmut Schönenberger
    Publication type:
    Article
    7